These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7846311)

  • 21. Distinguishing between models of carcinogenesis: the role of clonal expansion.
    Kopp-Schneider A; Portier CJ
    Fundam Appl Toxicol; 1991 Oct; 17(3):601-13. PubMed ID: 1794662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistage carcinogenesis.
    Lancet; 1980 Feb; 1(8163):295. PubMed ID: 6101747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The time to tumor approach in risk assessment.
    Albert RE
    Basic Life Sci; 1986; 38():551-6. PubMed ID: 3741347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in the multistage modeling of cohort data for carcinogenic risk assessment.
    Mazumdar S; Redmond CK; Costantino JP; Patwardhan RN; Zhou SY
    Environ Health Perspect; 1991 Jan; 90():271-7. PubMed ID: 2050072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Multiple Chemicals and Actions Model of carcinogenesis. A possible new approach to developing prevention strategies for environmental carcinogenesis.
    Battershill JM
    Hum Exp Toxicol; 2005 Nov; 24(11):547-58. PubMed ID: 16323570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Armitage-Doll two-stage model: implications and extension.
    Chen CW
    Risk Anal; 1993 Jun; 13(3):273-9. PubMed ID: 8341806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologically motivated two-stage model for cancer risk assessment.
    Moolgavkar SH
    Toxicol Lett; 1988 Oct; 43(1-3):139-50. PubMed ID: 3176062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity in multistage carcinogenesis and mixture modeling.
    Gsteiger S; Morgenthaler S
    Theor Biol Med Model; 2008 Jul; 5():13. PubMed ID: 18644142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundamental carcinogenic processes and their implications for low dose risk assessment.
    Crump KS; Hoel DG; Langley CH; Peto R
    Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
    Melnick RL; Kohn MC; Portier CJ
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and the genetics of environmental cancer.
    Shields PG; Harris CC
    JAMA; 1991 Aug; 266(5):681-7. PubMed ID: 2072479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis.
    van Leeuwen IM; Zonneveld C
    Mutat Res; 2001 Oct; 489(1):17-45. PubMed ID: 11673088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effect of multiple carcinogens and synergy index.
    Kawaguchi I; Doi M; Kakinuma S; Shimada Y
    J Theor Biol; 2006 Nov; 243(1):143-51. PubMed ID: 16860345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment.
    Trosko JE; Upham BL
    Mutagenesis; 2005 Mar; 20(2):81-92. PubMed ID: 15784692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multistage model of carcinogenesis incorporating DNA damage and repair.
    Portier CJ; Kopp-Schneider A
    Risk Anal; 1991 Sep; 11(3):535-43. PubMed ID: 1947359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multistage models of carcinogenesis.
    Armitage P
    Environ Health Perspect; 1985 Nov; 63():195-201. PubMed ID: 3908088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.